可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Kanda T,Mcmanus JW,Nagai R,et al. Modification of viral myocarditis in mice by interleudin-6[J].Circ Res ,1996, 78(5): 848-856.
[2] 王向宇,吴可贵,林经安.病毒性心肌炎小鼠模型的建立[J].福建医学院学报, 1995,29(3):295-297.
[3] Gauntt CJ,Hihdon AL,Arizpe HM,et al. Epitopes shared between coxsackievirus B3(CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis[J].Clin Immunol Immunopathol, 1993, 68(2): 129-134.
[4] Drucker NA,Colan SD,Lewis AB,et al.γ-globulin treatment of acute myocarditis in the pediatric population[J].Circulation, 1994,89:252-257.
[5] Takada H,Kishinoto C,Hiraoka Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3model [J].Circulation, 1995, 92: 1604-1611.
[6] Darville T,Milligan LB,Laffoon KK. Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production[J].Infect Immun,1997,65(2):366-372.
[7] Groothius JR, Simoes EA,Leuin MJ,et al. Prophylatic administration of respiratory syncytial virus immune globulin to high-risk infants and young children[J]. N Engl J Med,1993,329:1524-1530.
[8] Dalakas MC,Illa I,Bambrosia MJ, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis[J].N Engl J Med, 1993, 329: 1993 -2000.